75704-51-7 Usage
General Description
1-Amino-5,6,7,8-tetrahydroisoquinoline is a chemical compound with the molecular formula C9H11N. It is a derivative of isoquinoline and contains an amino group attached to a tetrahydroisoquinoline ring. 1-Amino-5,6,7,8-tetrahydroisoquinoline is used in pharmaceutical research and drug development, particularly in the study and synthesis of potential central nervous system drugs. It is also being investigated for its potential anti-inflammatory and analgesic properties. 1-Amino-5,6,7,8-tetrahydroisoquinoline has shown promise in preclinical studies for its ability to modulate neurotransmitter systems and has the potential to be developed into therapeutic agents for neurological and psychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 75704-51-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,7,0 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 75704-51:
(7*7)+(6*5)+(5*7)+(4*0)+(3*4)+(2*5)+(1*1)=137
137 % 10 = 7
So 75704-51-7 is a valid CAS Registry Number.
75704-51-7Relevant articles and documents
And circular PI3K inhibitors (by machine translation)
-
Paragraph 0389; 0390; 0391, (2016/10/08)
The invention belongs to the field of medical technology, in particular to general formula (I) and of the everted shown in the PI3K inhibitor, or a pharmaceutically acceptable salt, ester, stereo isomers, solvates, wherein R 1, R 2, R 3 as defined in the specification. The invention also relates to methods of preparing such compounds, pharmaceutical formulations containing these compounds and pharmaceutical compositions, use of these compounds in the preparation and treatment and/or prevention of proliferative diseases of application of the medicament. (by machine translation)
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
-
, (2008/06/13)
Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. STR1
